Eravacycline
Back to searchMolecule Structure
Scientific Name
Eravacycline
Description of the Drug
Eravacycline is a tetracycline antibiotic used to treat complicated intra-abdominal infections.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB12329
http://www.drugbank.ca/drugs/DB12329
Brand Name(s)
Tp-434
Company Owner(s)
Tetraphase Pharmaceuticals Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Bacterial 70S ribosome | PROTEIN NUCLEIC-ACID COMPLEX | INHIBITOR | CHEMBL2363135 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL10040430 | ||
| DrugBank | DB12329 | ||
| PubChem: Thomson Pharma | 99313545 | ||
| Nikkaji | J3.052.260E | ||
| DrugCentral | 5294 | ||
| rxnorm | XERAVA | ERAVACYCLINE DIHYDROCHLORIDE | ERAVACYCLINE |
| PubChem: Drugs of the Future | 123055450 |
